TOP TIERMARKET NEWSWIRE

News & sentiment

TURN THERAPEUTICS IN (TTRX) — News & AI sentiment

TURN THERAPEUTICS IN (TTRX) news roundup. 2 stories in the past week, 9 over 30 days. Average 30-day sentiment is 53.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

2

avg sentiment 58/100

30d stories

9

avg sentiment 53.2/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

TTRX news in the last 24 hours, 7 days, 30 days and 90 days

How much TTRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	TTRX stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	2	58/100	TTRX headlines →
Last 30 days	9	53.2/100	TTRX headlines →
Last 90 days	24	53/100	TTRX headlines →

Latest stories on TTRX

WBB Securities upgrades Turn Therapeutics stock rating to hold

Investing.com Analyst Ratings58 · neutralanalyst

5d ago

Turn Therapeutics upgraded to Hold from Sell at WBB Securities

The Fly58 · neutralanalyst

5d ago

U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat

StockTitan56 · neutralproduct/pr

Oct 21

Turn Therapeutics participates in a conference call with BTIG

The Fly52 · neutralgeneral

Oct 20

Turn Therapeutics Updates GX-03 Program and Pipeline Outlook

TipRanks55 · neutralproduct/pr

Oct 7

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Oct 6

TTRX Options Data Summary for Turn Therapeutics Inc

Barchart50 · neutralgeneral

Oct 3

TTRX Time & Sales for Turn Therapeutics Stock

Barchart50 · neutralgeneral

Oct 3

TTRX Long Call Condor for Turn Therapeutics Stock

Barchart50 · neutralgeneral

Oct 3

Lucid Capital Markets initiates Turn Therapeutics stock with buy rating

Investing.com Analyst Ratings61 · neutralanalyst

Sep 24

Turn Therapeutics initiated with a Buy at Lucid Capital

The Fly61 · neutralanalyst

Sep 24

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Sep 10

Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum

StockTitan56 · neutralgeneral

Sep 10

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Sep 9

Turn Therapeutics appoints Redfield as Chief Scientific Officer

The Fly56 · neutralgeneral

Sep 9

Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer

StockTitan63 · neutralproduct/pr

Sep 9

Turn Therapeutics announces publication of peer-reviewed research on GX-03

The Fly56 · neutralproduct/pr

Aug 20

Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch

StockTitan63 · neutralproduct/pr

Aug 20

Turn Therapeutics Reports Unregistered Cashless Warrant Share Issuance

TipRanks34 · bearishgeneral

Aug 18

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 18

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 17

Turn Therapeutics Inc. GAAP EPS of -$0.20

Seeking Alpha34 · bearishearnings

Aug 13

Turn Therapeutics Inc. (TTRX) files 8-K

SEC 8-K50 · neutralgeneral

Aug 12

Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results

StockTitan59 · neutralearnings

Aug 12

Turn Therapeutics Updates GX-03 Investor Presentation and Pipeline

TipRanks56 · neutralproduct/pr

Jul 28

Open TTRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →